Skip to main content
. 2020 Aug 20;64(9):e00836-20. doi: 10.1128/AAC.00836-20

TABLE 1.

Combination effect of ATI-2173 plus other anti-HBV compounds on HBV activity in primary human hepatocytes.

Compound combined with ATI-2173 Combination indexa Combination effect
Entecavir 38.62 Minor synergism
GLS4 7.59 Additive
Lamivudine −5.86 Additive
Tenofovir 8.56 Additive
Adefovir 32.85 Minor synergism
a

A combination index of <25 is considered additive, while 25 to 50 is considered minor synergism.